Detalhe da pesquisa
1.
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.
Lancet
; 395(10237): 1613-1626, 2020 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32580883
2.
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.
Lancet
; 390(10099): 1048-1060, 2017 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28779963
3.
New challenges in psycho-oncology: An embodied approach to body image.
Psychooncology
; 28(2): 211-218, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30488572
4.
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.
Lancet Oncol
; 14(11): 1086-1094, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24055415
5.
One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT.
Health Technol Assess
; 27(25): 1-176, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37991196
6.
Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials.
Lancet Oncol
; 11(3): 231-40, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20138809
7.
Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial.
Lancet
; 373(9676): 1681-92, 2009 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-19447249
8.
Long-Term Evaluation of Women Referred to a Breast Cancer Family History Clinic (Manchester UK 1987-2020).
Cancers (Basel)
; 12(12)2020 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33317064
9.
Can patient-reported outcomes be used instead of clinician-reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial.
Radiother Oncol
; 134: 220-230, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31005219
10.
Patient-Reported Outcomes Over 5 Years After Whole- or Partial-Breast Radiotherapy: Longitudinal Analysis of the IMPORT LOW (CRUK/06/003) Phase III Randomized Controlled Trial.
J Clin Oncol
; 37(4): 305-317, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30532984
11.
Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review.
Lancet
; 369(9577): 1929-37, 2007 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-17544497
12.
Clinical interpretation of quality-of-life outcomes: an investigation of data from the randomized trial of gemcitabine plus paclitaxel compared with paclitaxel alone for advanced breast cancer.
Breast J
; 14(3): 228-35, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18433403
13.
The impact of age and clinical factors on quality of life in early breast cancer: an analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial).
Breast
; 16(3): 241-51, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17236771
14.
Ifosfamide, carboplatin, and etoposide with midcycle vincristine versus standard chemotherapy in patients with small-cell lung cancer and good performance status: clinical and quality-of-life results of the British Medical Research Council multicenter randomized LU21 trial.
J Clin Oncol
; 23(33): 8371-9, 2005 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16293867
15.
A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer.
Lung Cancer
; 49(3): 395-400, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15908042
16.
Risk communication strategies: state of the art and effectiveness in the context of cancer genetic services.
Eur J Hum Genet
; 11(10): 725-36, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14512961
17.
Re: risk-reduction mastectomy: clinical issues and research needs.
J Natl Cancer Inst
; 94(4): 307-8, 2002 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-11854394
18.
The course of anxiety and depression over 5 years of follow-up and risk factors in women with early breast cancer: results from the UK Standardisation of Radiotherapy Trials (START).
Breast
; 19(2): 84-91, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20042336
19.
Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent.
Cancer Epidemiol Biomarkers Prev
; 18(8): 2318-24, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19661091
20.
Do women understand the odds? Risk perceptions and recall of risk information in women with a family history of breast cancer.
Community Genet
; 6(4): 214-23, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-15331867